{"id":"W4405500642","doi":"10.51731/cjht.2024.1047","title":"Brentuximab Vedotin (Adcetris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Reimbursement; Dacarbazine; Vinblastine; Medicine; Hodgkin lymphoma; Doxorubicin; Oncology; Internal medicine; Pharmacology; Lymphoma; Chemotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007012004,0.0002125977,0.0002921634,0.0008341419,0.0002059336,0.0006496911,0.00029557,0.0002666985,0.0031228],"category_scores_gemma":[0.00104196,0.00006485965,0.0002759231,0.0007986432,0.0001846489,0.0003011476,0.0001585642,0.0004585698,0.0005693726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002486527,"about_ca_system_score_gemma":0.002622949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03157261,"about_ca_topic_score_gemma":0.1215323,"domain_scores_codex":[0.999523,0.00007150056,0.00003451927,0.00003764309,0.0002854461,0.00004774679],"domain_scores_gemma":[0.9994621,0.0001271057,0.0001127204,0.00001011723,0.0002379782,0.00005012844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003873173,0.00005723249,0.001813055,0.003671634,0.0001419206,0.0002289891,0.0000397211,0.0003740523,0.004708793,0.002185945,0.03571441,0.9506769],"study_design_scores_gemma":[0.0002303345,0.0005647524,0.00891223,0.002145454,0.0002508377,0.001593482,0.000070036,0.0001918967,0.005129722,0.0003702714,0.9805222,0.00001873334],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01252044,0.94696,0.001131761,0.002282119,0.0003690713,0.0001277503,0.0011428,0.00008964576,0.03537644],"genre_scores_gemma":[0.208347,0.7577825,0.005050456,0.002666182,0.0003095485,0.0001082928,0.0021988,0.00002678338,0.02351042],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03157261,"threshold_uncertainty_score":0.0627777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0252575892802914,"score_gpt":0.3040635935498684,"score_spread":0.278806004269577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}